Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
Based on the Liposomes Drug Delivery market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Liposomes Drug Delivery market covered in Chapter 5:
Kingond Pharm
Johnson & Johnson
Sun Pharmaceutical
Sigma-Tau Group
Novartis
Teva Pharmaceutical
Spectrum Pharmaceuticals
CSPC
Fudan-Zhangjiang
Shanghai New Asia
Crucell
Celsion Corporation
Luye Pharma
Gilead Sciences
Pacira
In Chapter 6, on the basis of types, the Liposomes Drug Delivery market from 2015 to 2025 is primarily split into:
Liposomal Paclitaxel
Liposomal Amphoteracin B
Liposomal doxorubicin
In Chapter 7, on the basis of applications, the Liposomes Drug Delivery market from 2015 to 2025 covers:
Cancer Therapy ( Tumor therapy)
Fungal Infection Therapy
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Liposomes Drug Delivery Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Kingond Pharm
5.1.1 Kingond Pharm Company Profile
5.1.2 Kingond Pharm Business Overview
5.1.3 Kingond Pharm Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Kingond Pharm Liposomes Drug Delivery Products Introduction
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Company Profile
5.2.2 Johnson & Johnson Business Overview
5.2.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Johnson & Johnson Liposomes Drug Delivery Products Introduction
5.3 Sun Pharmaceutical
5.3.1 Sun Pharmaceutical Company Profile
5.3.2 Sun Pharmaceutical Business Overview
5.3.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Sun Pharmaceutical Liposomes Drug Delivery Products Introduction
5.4 Sigma-Tau Group
5.4.1 Sigma-Tau Group Company Profile
5.4.2 Sigma-Tau Group Business Overview
5.4.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Sigma-Tau Group Liposomes Drug Delivery Products Introduction
5.5 Novartis
5.5.1 Novartis Company Profile
5.5.2 Novartis Business Overview
5.5.3 Novartis Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Novartis Liposomes Drug Delivery Products Introduction
5.6 Teva Pharmaceutical
5.6.1 Teva Pharmaceutical Company Profile
5.6.2 Teva Pharmaceutical Business Overview
5.6.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Teva Pharmaceutical Liposomes Drug Delivery Products Introduction
5.7 Spectrum Pharmaceuticals
5.7.1 Spectrum Pharmaceuticals Company Profile
5.7.2 Spectrum Pharmaceuticals Business Overview
5.7.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Spectrum Pharmaceuticals Liposomes Drug Delivery Products Introduction
5.8 CSPC
5.8.1 CSPC Company Profile
5.8.2 CSPC Business Overview
5.8.3 CSPC Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 CSPC Liposomes Drug Delivery Products Introduction
5.9 Fudan-Zhangjiang
5.9.1 Fudan-Zhangjiang Company Profile
5.9.2 Fudan-Zhangjiang Business Overview
5.9.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Fudan-Zhangjiang Liposomes Drug Delivery Products Introduction
5.10 Shanghai New Asia
5.10.1 Shanghai New Asia Company Profile
5.10.2 Shanghai New Asia Business Overview
5.10.3 Shanghai New Asia Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Shanghai New Asia Liposomes Drug Delivery Products Introduction
5.11 Crucell
5.11.1 Crucell Company Profile
5.11.2 Crucell Business Overview
5.11.3 Crucell Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Crucell Liposomes Drug Delivery Products Introduction
5.12 Celsion Corporation
5.12.1 Celsion Corporation Company Profile
5.12.2 Celsion Corporation Business Overview
5.12.3 Celsion Corporation Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Celsion Corporation Liposomes Drug Delivery Products Introduction
5.13 Luye Pharma
5.13.1 Luye Pharma Company Profile
5.13.2 Luye Pharma Business Overview
5.13.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Luye Pharma Liposomes Drug Delivery Products Introduction
5.14 Gilead Sciences
5.14.1 Gilead Sciences Company Profile
5.14.2 Gilead Sciences Business Overview
5.14.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Gilead Sciences Liposomes Drug Delivery Products Introduction
5.15 Pacira
5.15.1 Pacira Company Profile
5.15.2 Pacira Business Overview
5.15.3 Pacira Liposomes Drug Delivery Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Pacira Liposomes Drug Delivery Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Liposomes Drug Delivery Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Liposomes Drug Delivery Sales and Market Share by Types (2015-2020)
6.1.2 Global Liposomes Drug Delivery Revenue and Market Share by Types (2015-2020)
6.1.3 Global Liposomes Drug Delivery Price by Types (2015-2020)
6.2 Global Liposomes Drug Delivery Market Forecast by Types (2020-2025)
6.2.1 Global Liposomes Drug Delivery Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Liposomes Drug Delivery Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Liposomes Drug Delivery Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Liposomes Drug Delivery Sales, Price and Growth Rate of Liposomal Paclitaxel
6.3.2 Global Liposomes Drug Delivery Sales, Price and Growth Rate of Liposomal Amphoteracin B
6.3.3 Global Liposomes Drug Delivery Sales, Price and Growth Rate of Liposomal doxorubicin
6.4 Global Liposomes Drug Delivery Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Liposomal Paclitaxel Market Revenue and Sales Forecast (2020-2025)
6.4.2 Liposomal Amphoteracin B Market Revenue and Sales Forecast (2020-2025)
6.4.3 Liposomal doxorubicin Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Liposomes Drug Delivery Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Liposomes Drug Delivery Sales and Market Share by Applications (2015-2020)
7.1.2 Global Liposomes Drug Delivery Revenue and Market Share by Applications (2015-2020)
7.2 Global Liposomes Drug Delivery Market Forecast by Applications (2020-2025)
7.2.1 Global Liposomes Drug Delivery Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Liposomes Drug Delivery Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Liposomes Drug Delivery Revenue, Sales and Growth Rate of Cancer Therapy ( Tumor therapy) (2015-2020)
7.3.2 Global Liposomes Drug Delivery Revenue, Sales and Growth Rate of Fungal Infection Therapy (2015-2020)
7.3.3 Global Liposomes Drug Delivery Revenue, Sales and Growth Rate of Others (2015-2020)
7.4 Global Liposomes Drug Delivery Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Cancer Therapy ( Tumor therapy) Market Revenue and Sales Forecast (2020-2025)
7.4.2 Fungal Infection Therapy Market Revenue and Sales Forecast (2020-2025)
7.4.3 Others Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Liposomes Drug Delivery Sales by Regions (2015-2020)
8.2 Global Liposomes Drug Delivery Market Revenue by Regions (2015-2020)
8.3 Global Liposomes Drug Delivery Market Forecast by Regions (2020-2025)
9 North America Liposomes Drug Delivery Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Liposomes Drug Delivery Market Sales and Growth Rate (2015-2020)
9.3 North America Liposomes Drug Delivery Market Revenue and Growth Rate (2015-2020)
9.4 North America Liposomes Drug Delivery Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Liposomes Drug Delivery Market Analysis by Country
9.6.1 U.S. Liposomes Drug Delivery Sales and Growth Rate
9.6.2 Canada Liposomes Drug Delivery Sales and Growth Rate
9.6.3 Mexico Liposomes Drug Delivery Sales and Growth Rate
10 Europe Liposomes Drug Delivery Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Liposomes Drug Delivery Market Sales and Growth Rate (2015-2020)
10.3 Europe Liposomes Drug Delivery Market Revenue and Growth Rate (2015-2020)
10.4 Europe Liposomes Drug Delivery Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Liposomes Drug Delivery Market Analysis by Country
10.6.1 Germany Liposomes Drug Delivery Sales and Growth Rate
10.6.2 United Kingdom Liposomes Drug Delivery Sales and Growth Rate
10.6.3 France Liposomes Drug Delivery Sales and Growth Rate
10.6.4 Italy Liposomes Drug Delivery Sales and Growth Rate
10.6.5 Spain Liposomes Drug Delivery Sales and Growth Rate
10.6.6 Russia Liposomes Drug Delivery Sales and Growth Rate
11 Asia-Pacific Liposomes Drug Delivery Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Liposomes Drug Delivery Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Liposomes Drug Delivery Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Liposomes Drug Delivery Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Liposomes Drug Delivery Market Analysis by Country
11.6.1 China Liposomes Drug Delivery Sales and Growth Rate
11.6.2 Japan Liposomes Drug Delivery Sales and Growth Rate
11.6.3 South Korea Liposomes Drug Delivery Sales and Growth Rate
11.6.4 Australia Liposomes Drug Delivery Sales and Growth Rate
11.6.5 India Liposomes Drug Delivery Sales and Growth Rate
12 South America Liposomes Drug Delivery Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Liposomes Drug Delivery Market Sales and Growth Rate (2015-2020)
12.3 South America Liposomes Drug Delivery Market Revenue and Growth Rate (2015-2020)
12.4 South America Liposomes Drug Delivery Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Liposomes Drug Delivery Market Analysis by Country
12.6.1 Brazil Liposomes Drug Delivery Sales and Growth Rate
12.6.2 Argentina Liposomes Drug Delivery Sales and Growth Rate
12.6.3 Columbia Liposomes Drug Delivery Sales and Growth Rate
13 Middle East and Africa Liposomes Drug Delivery Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Liposomes Drug Delivery Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Liposomes Drug Delivery Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Liposomes Drug Delivery Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Liposomes Drug Delivery Market Analysis by Country
13.6.1 UAE Liposomes Drug Delivery Sales and Growth Rate
13.6.2 Egypt Liposomes Drug Delivery Sales and Growth Rate
13.6.3 South Africa Liposomes Drug Delivery Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Liposomes Drug Delivery Market Size and Growth Rate 2015-2025
Table Liposomes Drug Delivery Key Market Segments
Figure Global Liposomes Drug Delivery Market Revenue ($) Segment by Type from 2015-2020
Figure Global Liposomes Drug Delivery Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Liposomes Drug Delivery
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Kingond Pharm Company Profile
Table Kingond Pharm Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Summary: Get latest Market Research Reports on Liposomes Drug Delivery. Industry analysis & Market Report on Liposomes Drug Delivery is a syndicated market report, published as Global Liposomes Drug Delivery Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Liposomes Drug Delivery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.